Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Kinetics of Levobupivacaine After Transversus Abdominis Plane (TAP) Block in Abdominal Surgery: A Prospective Study and Definition of a Safety Window for Intravenous Lidocaine Administration

NCT07581275 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT07581275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07581275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Kinetics of Levobupivacaine After Transversus Abdominis Plane (TAP) Block in Abdominal Surgery: A Prospective Study and Definition of a Safety Window for Intravenous Lidocaine Administration
Lead sponsor
University of Liege
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
December 15, 2026
Enrollment
26 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal surgery patients, levobupivacaine, local anaesthetic systemic toxicity, pharmacokinetic analysis, transversus abdominis plane (tap) block